Vendor, Coppell, TX
Verily Health Inc.
UEI U92RDNGXL1E5, CAGE 7NTV3
4 awards and $38,215,087 obligated between January 12, 2024 and September 30, 2026, 75% under full and open competition, against 6.3 offers on average where reported. 1 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| Centers for Disease Control and Prevention | $37,965,087 |
| National Institutes of Health | $250,000 |
Industries
NAICS on the awards, by dollars.
| Testing Laboratories and ServicesNAICS 541380 | $32,384,321 |
| All Other Professional, Scientific, and Technical ServicesNAICS 541990 | $5,580,766 |
| Other Computer Related ServicesNAICS 541519 | $250,000 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 3 |
| Not Competed | 1 |
| Definitive Contract | 3 |
| Delivery Order | 1 |
Hear when Verily Health Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Verily Health Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $5,580,766
- Soonest
- September 28, 2027
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling testing laboratories and services to Centers for Disease Control and Prevention, by dollars.
| Ginkgo Bioworks, Inc.Boston, MA | $120,345,607 |
| J. Craig Venter Institute, Inc.La Jolla, CA | $1,718,350 |
| Bureau Veritas North America Inc.Novi, MI | $1,093,576 |
| GT Molecular, Inc.Fort Collins, CO | $1,029,779 |
| Eurofins Environment Testing Northern California LLCWest Sacramento, CA | $454,663 |
| Bioplastics/Cyclertest Inc.Durham, NC | $96,470 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Wastewater Surveillance Testing
Centers for Disease Control and Prevention, CDC Office of Acquisition Services
Award noticeNAICS 541380South San Francisco, CA75D30124C18440Awarded to Verily Health Inc. for $38,760,800
Posted Jan 12, 2024
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75D30124C18440Definitive Contract, January 12, 2024, Full and Open Competition, 9 offersSolicitation | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Wastewater Surveillance TestingNAICS 541380, PSC Q301 | $42,317,282 |
| 75D30126F00001Delivery Order, September 29, 2026, Full and Open Competition | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Scalable Wastewater Surveillance for Routine and Emerging Infectious Disease Pathogens Eo 14398NAICS 541990, PSC Q301 | $5,580,766 |
| 75N95024C00037Definitive Contract, September 25, 2024, Not Competed, 1 offers | National Institutes of Health NidaNational Institutes of Health | Verily Life Sciences LLC:1478747 [24-006978]NAICS 541519, PSC 7A21 | $250,000 |
| 75D30123C17984Definitive Contract, February 6, 2024, Full and Open Competition, 9 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Wastewater TestingNAICS 541380, PSC Q301 | -$9,932,961 |
- Places of performance
- CaliforniaTexas
- Product and service codes
- Q301 Reference Laboratory Testing7A21 Business Application off-the-shelf software delivered by perpetual license, which also encompasses enterprise level software enabling mission capability and business operational support.
- Transactions
- 12 across 4 awards